Crossmark

The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care

Crossref DOI link: https://doi.org/10.1007/s00702-018-1918-9

Published Online: 2018-08-22

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fründt, Odette

Mainka, Tina

Schönwald, Beate

Müller, Bianca

Dicusar, Polina

Gerloff, Christian

Buhmann, Carsten
License Information

Text and Data Mining valid from 2018-08-22
More Information

Article History

Received: 18 June 2018

Accepted: 20 August 2018

First Online: 22 August 2018

Compliance with ethical standards

:

: C. Buhmann received a grant from the Georg & Jürgen Rickertsen Stiftung Hamburg, served on a scientific advisory boards for Bial and Zambon and received honoraria for lectures from Abbvie, Bial, GE Healthcare, Grünenthal, Licher and UCB Pharma. C. Gerloff is supported by the German Research Foundation (DFG Ge 844/4-1, Ge 844/5-1, SFB 936/C1, Z1, Z2, TRR 169/A03) and the EU (FP7-HEALTH-2011-278276), and has received honoraria as a speaker or consultant from Amgen, Bayer Vital, BMS, Boehringer Ingelheim, Sanofi Aventis. O. Fründt was supported by AbbVie and Abbott/St.Jude Medical to attend symposia/congresses. B. Schönwald received honoraria for lectures from Licher and Zambon. B. Müller received financial compensation for a lecture from Grünenthal. T. Mainka and P. Dicusar report no conflicts of interest to disclose.

: For this type of study formal consent is not required (reference number of the Hamburg ethics committee PV5799, WF-028/18).

: As this is a retrospective analysis of clinical data, this is not applicable. All patients signed a treatment contract with our clinic.